文献速递腹部技术与安全US

基于超声的肝脏脂肪定量:现状与未来方向

Ultrasound-based hepatic fat quantification: current status and future directions.
PubMed 文献 · Clin Radiol · 2022-11-18

本文综述了非酒精性脂肪性肝病(NAFLD)的超声评估方法。传统B型超声定性指标存在观察者间差异大、对轻度脂肪变不敏感的问题;基于背向散射、衰减和声速的定量超声参数在前瞻性研究中显示出对低级别脂肪变和NAFLD的良好诊断性能。综述旨在明确超声评估肝脂肪变的临床需求、简述各技术物理原理并评估市售技术的证据基础。

要点

  • 传统B型超声定性指标对轻度脂肪变不敏感且观察者间差异显著。
  • 定量超声参数(背向散射、衰减、声速)在低级别脂肪变中诊断性能良好。
  • 需结合临床需求选择超声定量技术并认识其证据局限性。

核心结论

  • 定量超声参数作为肝脂肪变生物标志物在前瞻性研究中诊断性能良好,甚至对低级别脂肪变和NAFLD也有效。

研究设计与样本

  • 本文为综述,旨在明确超声评估肝脂肪变的临床需求、简述相关技术物理原理并评估市售超声技术的证据基础。

关键影像表现/征象

  • 传统B型超声可见肝实质回声较邻近肾皮质增高,但存在显著观察者间差异且对轻度脂肪变不敏感。
  • 定量超声方法依赖于脂肪肝中背向散射、衰减和声速的变化。

临床应用与阅片要点

  • 日常阅片可关注肝实质回声与肾皮质对比,但需认识其观察者间差异和对轻度脂肪变不敏感的限制。
  • 定量超声参数有望用于肝脂肪变的评估和监测,尤其对低级别脂肪变和NAFLD。

局限性

  • 传统B型超声定性指标存在显著观察者间差异且对轻度脂肪变不敏感。
  • 组织病理学有创、MRI可用性有限,而超声定量技术的证据基础仍需评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease from fatty accumulation (steatosis), necro-inflammation though to fibrosis. It is of increasing global prevalence as a hepatic manifestation of the metabolic syndrome. Although accurate histopathology and magnetic resonance imaging techniques for hepatic fat quantification exist, these are limited by invasiveness and availability, respectively. Ultrasonography is potentially ideal for assessing and monitoring hepatic steatosis given the examination is rapid and readily available. Traditional ultrasound methods include qualitative B-mode for imaging markers, such as increased hepatic parenchymal echogenicity compared to adjacent renal cortex are commonplace; however, there is acknowledged significant interobserver variability and they are suboptimal for detecting mild steatosis. Recently quantitative ultrasound metrics have been investigated as biomarkers for hepatic steatosis. These methods rely on changes in backscatter, attenuation, and speed of sound differences encountered in a steatotic liver. Prospective studies using quantitative ultrasound parameters show good diagnostic performance even at low steatosis grades and in NAFLD. This review aims to define the clinical need for ultrasound-based assessments of liver steatosis, to describe briefly the physics that underpins the various techniques available, and to assess the evidence base for the effectiveness of the techniques that are available commercially from various ultrasound vendors.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Seneviratne, Fang, Sidhu, et al. Ultrasound-based hepatic fat quantification: current status and future directions. Clin Radiol. 2022. PMID: 36411088. doi:10.1016/j.crad.2022.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。